DUR seeks physician feedback
August 15, 2012
The Iowa Medicaid Drug Utilization Review (DUR) Commission is seeking physician feedback on proposed changes to clinical prior authorization criteria. The proposed changes affect the following:
- vemurafenib (ZelborafTM)
- biologicals for arthritis
Click here (PDF 100KB) for details of the proposed changes. Physicians wishing to provide comments on the proposed changes are asked to contact by September 5, 2012.